NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Research
Agency / Source: Coalition for the Life Sciences (CLS)

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

FY13 Funding Should Support American Health, Economic Growth, and Global Competitiveness Says CLS - The Coalition for the Life Sciences (CLS) called on Congress to continue its historic, strong support for the National Institutes of Health (NIH) - CoalitionforLifeSciences.org
FY13 Funding Should Support American Health, Economic Growth, and Global Competitiveness Says CLS

 

NewswireTODAY - /newswire/ - Bethesda, MD, United States, 2012/03/01 - The Coalition for the Life Sciences (CLS) called on Congress to continue its historic, strong support for the National Institutes of Health (NIH) - CoalitionforLifeSciences.org.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The Coalition for the Life Sciences (CLS) today called on Congress to continue its historic, strong support for the National Institutes of Health (NIH), stating it is a proven pathway to better treatment options for American families, strengthens the U.S. economy, and maintains American leadership in the competitive global research enterprise.

“Congress has a bipartisan history of support for the NIH, understanding that investments in science and discovery are the foundations that lead to better health care and a stronger economy,” said Keith Yamamoto, chair of the CLS, continued,“The CLS urges Congress to fund the NIH at a level of at least $32 billion.”

President Abama’s proposed 2013 NIH budget recommends $30.7 billion, a flat funding level that in fact loses ground for vital research when inflation is included. Given several recent years of flat or near-flat funding, biomedical research inflation has eaten away at the buying power of the NIH budget, leaving it20% lower than it was a decade ago. The President’s plan recommends that most NIH institutes receive roughly the same amount of funding as in FY12, except for select new investments in translational science.

Additionally, Yamamoto noted,“It is essential that the NIH maintains a balanced research portfolio. A sustained, robust investment in fundamental discovery research is the only way to uncover the mechanisms of disease, and knowing those mechanisms will lead to treatments and cures.”Even as patients, scientists, and drug developers seek new ways to ameliorate disease,” Yamamoto noted that “much of what we need to know remains to be discovered.”

The scientific insights and breakthroughs that result in improved global health can most often be traced to research proposals initiated by individual investigators eager to ask and answer important and challenging scientific questions—including those that carry a high risk for failure.“That part of the budget absolutely demands public support, as the private sector will not take on those risks.” Yamamoto continued,“The best biomedical ideas, the heart of innovation, reside in the community of NIH-supported investigators at our universities and medical schools.”

CLS Director Lynn Marquis added,“The crucial research and discovery engine driven by NIH also supports nearly a half million high-paying jobs in the United States. These high-paying jobs are found in every state across the nation in universities, medical schools, hospitals, research institutes, small businesses, and at companies that produce the equipment, technology, and supplies used in research. If a constrained federal budget hinders medical innovation, jobs will be lost, cures won’t be forthcoming, and our standing as the world leader in biomedical research will be compromised.”

Yamamoto concluded,“Now is the time to foster the growth of the nation’s biomedical enterprise. Biomedical research will lower the cost of health care, bring life-saving treatments to patients who cannot afford to wait, and reinvigorate the economy.”

The Coalition for the Life Sciences (coalitionforlifesciences.org) is an alliance of six non-profit professional organizations working together to foster public policies that advance basic biological research and its applications in medicine and other fields. The issues addressed by the CLS include science education, professional training, and the funding, management, and oversight of scientific work, especially by the federal government.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Coalition for the Life Sciences (CLS)

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Research articles,
CATCH Visitors via Your Competitors Announcements!


FY13 Funding Should Support American Health, Economic Growth, and Global Competitiveness Says CLS

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Lynn Marquis - CoalitionforLifeSciences.org 
301-347-9309 lmarquis[.]coalitionforlifesciences.org
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Coalition for the Life Sciences (CLS) securities in any jurisdiction including any other companies listed or named in this release.

Research via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Coalition for the Life Sciences (CLS) / Company Profile


Read Research Most Recent Related Newswires:

Avance Clinical Honored with Frost & Sullivan’s 2025 Global Customer Value Leadership Award for Transformative Biotech CRO Services
Safran, INSA Rouen Normandie, the University of Rouen Normandie and the CNRS Launch 'FLAMES', their Joint Research Laboratory
ENPC and VINCI Enter into A Strategic Partnership Around Environmental Transition and Digital Transformation
Reborna Biosciences, Inc. Enters into a Research and Licensing Agreement with Ono Pharmaceutical
Southern Star Research Applauded by Frost & Sullivan for Delivering Comprehensive Clinical Trial Solutions and its Competitive Strategies
GCCL Applauded by Frost & Sullivan for Ensuring Consistent, Reliable Clinical Trial Data in APAC
Medeze Group Awarded Frost & Sullivan’s 2024 Southeast Asia Company of the Year for Delivering Highly Innovative Stem Cell and Longevity Solutions
World Congress DSA 2025 - The Frontiers in Intelligent Data and Signal Analysis, Dresden Germany July
Motorola Solutions Announces New Global R&D Centre in Ireland
Naval Group Announces A New Collaboration Between Public and Private Research Studying the Electromagnetism of Ships
BASF Researching CO2-neutral Production of Bio-based Fumarate Using Bacteria Found in Cow Stomachs
SCHOTT Receives Over €1.3 Million to Advance Nuclear Fusion Research
NASA’s Jet Propulsion Laboratory Enhances Public Safety with CentralSquare Technologies’ Pro Suite
BASF to Research on Alternatives to Animal Testing on Behalf of the European Chemicals Agency (ECHA)
NEC Joins Columbia University-led National Science Foundation Engineering Research Center for Smart Streetscapes (CS3)

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  BizJobs.com





 
  ©2005-2025 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)